Bioactivity of Three Salvia Species in Relation to Their Total Phenolic and Flavonoid Contents
- 作者: Sharopov F.1,2, Valiev A.2, Sobeh M.1, Arnold E.1, Winka M.1
- 
							隶属关系: 
							- Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
- Department of Pharmaceutical Technology, Avicenna Tajik State Medical University
 
- 期: 卷 52, 编号 7 (2018)
- 页面: 596-600
- 栏目: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/245362
- DOI: https://doi.org/10.1007/s11094-018-1866-6
- ID: 245362
如何引用文章
详细
Antioxidant, anti-inflammatory, cytotoxic activities and total phenolic and flavonoid contents of methanol extracts of three Salvia species including Salvia discolor, S. officinalis and S. sclarea were investigated. The compositions of extracts were analyzed by high performance liquid chromatography (HPLC) with a UV-DAD detector. The major component of extracts from aerial parts of Salvia species was rosmarinic acid (0.2 – 61.1%). The composition of methanol extract from aerial parts strongly differed from that of the root extract. The total phenolic and flavonoid contents per 100 g fresh weight ranged within 658.3 – 1805.9 mg of caffeic acid equivalent (CAE) and 13.0 – 184.9 mg of quercetin equivalent (QE), respectively. The highest DPPH• radical scavenging effect was observed for S. sclarea extract (with an IC50 of 21.6 μg/mL), while S. discolour extract exhibited the highest ABTS•+ radical scavenging ability (with IC50 of 53.0 μg/mL) among all extracts. All Salvia extracts showed remarkable cytotoxic effect toward human T-lymphoblast leukemia (CCRF-CEM) and adriamycin resistant leukemia (CEM/ADR 5000) with average IC50 values of 25.3 – 65 μg/mL and 34.5 – 89.8 μg/mL, respectively. A relatively strong effect against human breast adenocarcinoma (MCF-7) was observed for the S. officinalis extract, with an IC50 of 138.5 μg/mL.
作者简介
Farukh Sharopov
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University; Department of Pharmaceutical Technology, Avicenna Tajik State Medical University
							编辑信件的主要联系方式.
							Email: shfarukh@mail.ru
				                					                																			                												                	德国, 							Im Neuenheimer Feld 364, Heidelberg, D-69120; Rudaki 139, Dushanbe, 734003						
Abdujabbor Valiev
Department of Pharmaceutical Technology, Avicenna Tajik State Medical University
														Email: wink@uni-hd.de
				                					                																			                												                	塔吉克斯坦, 							Rudaki 139, Dushanbe, 734003						
Mansour Sobeh
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
														Email: wink@uni-hd.de
				                					                																			                												                	德国, 							Im Neuenheimer Feld 364, Heidelberg, D-69120						
Eva Arnold
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
														Email: wink@uni-hd.de
				                					                																			                												                	德国, 							Im Neuenheimer Feld 364, Heidelberg, D-69120						
Michael Winka
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
							编辑信件的主要联系方式.
							Email: wink@uni-hd.de
				                					                																			                												                	德国, 							Im Neuenheimer Feld 364, Heidelberg, D-69120						
补充文件
 
				
			 
						 
						 
					 
						 
						 
				 
  
  
  
  
  电邮这篇文章
			电邮这篇文章  开放存取
		                                开放存取 ##reader.subscriptionAccessGranted##
						##reader.subscriptionAccessGranted## 订阅存取
		                                		                                        订阅存取
		                                					